Drawing for TAURX

USPTO serial 79043574

TAURX

Reviewed by CopyMark Law Group

Reg. 3658141Status 780Registered
Filing date
Status date
Registration date
Jul 21, 2009
Examiner
HELLMAN, ELI J
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with TAURX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thad Chaloemtiarana

Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard & Geralds200 South Wacker Drive, Suite 2900CHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditions; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditions; [ first aid kits and ] diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditionsACTIVE—
009Computer software for facilitating research in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bioinformatics, clinical development and statistics, laboratory and diagnostic instruments, namely, computer software for use in the analysis and diagnosis of medical conditions; pre-recorded CD-ROMS and computer disks containing electronic publications, namely, test reports, [ magazines ] and manuals, and information in the fields of pre-clinical, clinical and pharmaceutical research and drug discovery and drug research; [ computer servers; ] pre-recorded magnetic data carriers and pre-recorded computer disks containing databases and information in the field of scientific, medical, drug, clinical, pharmaceutical, biological, biotechnical, bioinformatic and statistical researchACTIVE—
010Medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely, blood, brain, urine, cerebrospinal fluid (csf) analysis and testing apparatus; [ medical apparatus for introducing pharmaceutical preparations into the body, the foregoing for carrying out tests for genetic testing; ] medical testing apparatus for the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid (csf) analysis and tests; surgical and medical apparatus and instruments for facilitating the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid (csf) analysis and testsACTIVE—
016Printed matter, namely, [ albums, almanacs, ] booklets, books, catalogues, hand books, journals, manuals, [ magazines, periodicals, newspapers, ] pamphlets and prospectuses, all in the fields of biology, biotechnology, drugs, medicines, chemical preparations, pharmaceuticals, bioinformatics and scientific design, development and research and medical laboratory researchACTIVE—
035Retail store services featuring pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, [ scientific, measuring and teaching apparatus and instruments, ] computer software, [ surgical and medical apparatus and instruments, ] apparatus for carrying out tests for medical purposes, scientific and medical apparatus for use in tests, and printed matter, books, journals, [ magazines, ] leaflets, publications, printed tests, written reports in the field of medical and pharmaceutical researchACTIVE—
042[ Medical, pharmaceutical, genetic, biological and biotechnology research; design, research and development of drugs, pharmaceuticals and medicines for others; laboratory and medical laboratory research and development of drugs, pharmaceuticals and medicines for others; scientific development research and consultation in the fields of synthetic chemistry, organic chemistry, medicinal chemistry, pharmacological chemistry, anorgic chemistry, analytical chemistry, biological chemistry, radiochemistry, data analysis, informatics, bio-informatics, chem-informatics, computer aided design, artificial intelligence, neural networks, statistics, mathematics, physics and biophysics; biological development research and consultation in the fields of anatomy, pharmacology, pharmacokinetics, physiology, pathophysiology, aetiology, genomics, genetics, biochemicals, toxicology, neurochemistry, cellular biology, molecular biology, proteomics, pharmacological genetics and metabonomics; ] scientific research and development services for clinical development in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing [ ; preparation of reports of scientific and medical research concerning medicines, pharmaceuticals, genetics, biology, biotechnology and drugs; development of prognostic and diagnostic tools for others; providing research consultation and information in the fields of medical, pharmaceutical, genetic, biological, drug, clinical, statistical and biotechnological research ]ACTIVE—
044Medical services featuring health assessment surveys; providing information and consultancy relating to the aforesaid medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 10, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 10, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 10, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 22, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
Apr 22, 2020CANTCANCELLATION TERMINATED NO. 999999—
Apr 22, 2020CANDCANCELLATION DENIED NO. 999999—
Jan 9, 2020NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 9, 202071AGREGISTERED-SEC.71 ACCEPTED—
Jan 9, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 17, 2019ES71TEAS SECTION 71 RECEIVED—
Jul 21, 2018REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 15, 2018RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 8, 2017PETCCANCELLATION INSTITUTED NO. 999999—
Apr 28, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
May 26, 2016INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 26, 2016INPCINVALIDATION PROCESSED—
May 22, 2016INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 22, 2015NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 22, 201571AGREGISTERED-SEC.71 ACCEPTED—
Sep 10, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 20, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 21, 2015ES71TEAS SECTION 71 RECEIVED—
Mar 12, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 27, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 13, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 29, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 29, 2009FIMPFINAL DISPOSITION PROCESSED—
Oct 21, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 29, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 21, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 5, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 15, 2009NPUBNOTICE OF PUBLICATION—
Apr 1, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 30, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 30, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 30, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 30, 2009ALIEASSIGNED TO LIE—
Mar 30, 2009ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 27, 2009OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 12, 2009OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 12, 2009OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 28, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 28, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 28, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 22, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 22, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 22, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 14, 2007RFNTREFUSAL PROCESSED BY IB—
Nov 27, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 27, 2007RFRRREFUSAL PROCESSED BY MPU—
Nov 27, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 26, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2007DOCKASSIGNED TO EXAMINER—
Oct 12, 2007NWAPNEW APPLICATION ENTERED—
Oct 11, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance